Skip to content
healthcare.dev

Alka-Seltzer Hangover Relief

NDC 0280-0084, ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE, tablet, effervescent, from Bayer HealthCare LLC..

Product NDC
0280-0084
Status
Listed
Labeler
Bayer HealthCare LLC.
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0084 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAFFEINE65 mg/1
  • ASPIRIN500 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
0280-0084-010028000840110 POUCH in 1 CARTON (0280-0084-01) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0084-020028000840218 POUCH in 1 CARTON (0280-0084-02) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0084-030028000840360 POUCH in 1 CARTON (0280-0084-03) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0084-04002800084042 POUCH in 1 CARTON (0280-0084-04) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0084-05002800084051600 POUCH in 1 BOX (0280-0084-05) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0084-060028000840630 POUCH in 1 CARTON (0280-0084-06) / 2 TABLET, EFFERVESCENT in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0280-0084 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0084 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0280-0084. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.